168 related articles for article (PubMed ID: 16984370)
1. Nucleophosmin: a versatile molecule associated with hematological malignancies.
Naoe T; Suzuki T; Kiyoi H; Urano T
Cancer Sci; 2006 Oct; 97(10):963-9. PubMed ID: 16984370
[TBL] [Abstract][Full Text] [Related]
2. Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias.
Falini B; Nicoletti I; Bolli N; Martelli MP; Liso A; Gorello P; Mandelli F; Mecucci C; Martelli MF
Haematologica; 2007 Apr; 92(4):519-32. PubMed ID: 17488663
[TBL] [Abstract][Full Text] [Related]
3. MNDA binds NPM/B23 and the NPM-MLF1 chimera generated by the t(3;5) associated with myelodysplastic syndrome and acute myeloid leukemia.
Xie J; Briggs JA; Morris SW; Olson MO; Kinney MC; Briggs RC
Exp Hematol; 1997 Oct; 25(11):1111-7. PubMed ID: 9328447
[TBL] [Abstract][Full Text] [Related]
4. The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1.
Yoneda-Kato N; Look AT; Kirstein MN; Valentine MB; Raimondi SC; Cohen KJ; Carroll AJ; Morris SW
Oncogene; 1996 Jan; 12(2):265-75. PubMed ID: 8570204
[TBL] [Abstract][Full Text] [Related]
5. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis.
Bischof D; Pulford K; Mason DY; Morris SW
Mol Cell Biol; 1997 Apr; 17(4):2312-25. PubMed ID: 9121481
[TBL] [Abstract][Full Text] [Related]
6. Role of nucleophosmin in acute myeloid leukemia.
Meani N; Alcalay M
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1283-94. PubMed ID: 19761432
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia with mutated nucleophosmin (NPM1): molecular, pathological, and clinical features.
Falini B
Cancer Treat Res; 2010; 145():149-68. PubMed ID: 20306250
[TBL] [Abstract][Full Text] [Related]
8. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.
Colombo E; Martinelli P; Zamponi R; Shing DC; Bonetti P; Luzi L; Volorio S; Bernard L; Pruneri G; Alcalay M; Pelicci PG
Cancer Res; 2006 Mar; 66(6):3044-50. PubMed ID: 16540653
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
Falini B; Mecucci C; Tiacci E; Alcalay M; Rosati R; Pasqualucci L; La Starza R; Diverio D; Colombo E; Santucci A; Bigerna B; Pacini R; Pucciarini A; Liso A; Vignetti M; Fazi P; Meani N; Pettirossi V; Saglio G; Mandelli F; Lo-Coco F; Pelicci PG; Martelli MF;
N Engl J Med; 2005 Jan; 352(3):254-66. PubMed ID: 15659725
[TBL] [Abstract][Full Text] [Related]
10. Global proteome profiling of NPM/ALK-positive anaplastic large cell lymphoma.
Sjostrom C; Seiler C; Crockett DK; Tripp SR; Elenitoba Johnson KS; Lim MS
Exp Hematol; 2007 Aug; 35(8):1240-8. PubMed ID: 17560012
[TBL] [Abstract][Full Text] [Related]
11. Nucleophosmin regulates the stability and transcriptional activity of p53.
Colombo E; Marine JC; Danovi D; Falini B; Pelicci PG
Nat Cell Biol; 2002 Jul; 4(7):529-33. PubMed ID: 12080348
[TBL] [Abstract][Full Text] [Related]
12. Role of nucleophosmin in embryonic development and tumorigenesis.
Grisendi S; Bernardi R; Rossi M; Cheng K; Khandker L; Manova K; Pandolfi PP
Nature; 2005 Sep; 437(7055):147-53. PubMed ID: 16007073
[TBL] [Abstract][Full Text] [Related]
13. [Nucleophosmin mutations in hematological malignancies - review].
Luo ZP; Zhang L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):662-6. PubMed ID: 17605889
[TBL] [Abstract][Full Text] [Related]
14. STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expression.
Zhang Q; Wang HY; Liu X; Wasik MA
Nat Med; 2007 Nov; 13(11):1341-8. PubMed ID: 17922009
[TBL] [Abstract][Full Text] [Related]
15. Identification of multiple SNT-binding sites on NPM-ALK oncoprotein and their involvement in cell transformation.
Chikamori M; Fujimoto J; Tokai-Nishizumi N; Yamamoto T
Oncogene; 2007 May; 26(20):2950-4. PubMed ID: 17086210
[TBL] [Abstract][Full Text] [Related]
16. [Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice].
Merz H; Lange K; Nadrowitz R; Uckert W; Blankenstein T; Feller AC
Verh Dtsch Ges Pathol; 2003; 87():224-31. PubMed ID: 16888916
[TBL] [Abstract][Full Text] [Related]
17. NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia.
Falini B; Mecucci C; Saglio G; Lo Coco F; Diverio D; Brown P; Pane F; Mancini M; Martelli MP; Pileri S; Haferlach T; Haferlach C; Schnittger S
Haematologica; 2008 Mar; 93(3):439-42. PubMed ID: 18268276
[TBL] [Abstract][Full Text] [Related]
18. C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders.
Caudill JS; Sternberg AJ; Li CY; Tefferi A; Lasho TL; Steensma DP
Br J Haematol; 2006 Jun; 133(6):638-41. PubMed ID: 16704439
[TBL] [Abstract][Full Text] [Related]
19. Mutations of NPM1 gene in de novo acute myeloid leukaemia: determination of incidence, distribution pattern and identification of two novel mutations in Indian population.
Ahmad F; Mandava S; Das BR
Hematol Oncol; 2009 Jun; 27(2):90-7. PubMed ID: 19365794
[TBL] [Abstract][Full Text] [Related]
20. Absence of nucleophosmin 1 (NPM1) gene mutations in common solid cancers.
Jeong EG; Lee SH; Yoo NJ; Lee SH
APMIS; 2007 Apr; 115(4):341-6. PubMed ID: 17504301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
